Navigation Links
Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators,Published in Pediatrics

WARRINGTON, Pa., May 31, 2007 (PRIME NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) announces publication of the one-year follow-up results from its SELECT and STAR Phase 3 clinical trials for Surfaxin(r), in Pediatrics, the premier medical journal for pediatric healthcare practitioners. The long-term data from the SELECT and STAR trials concluded that Surfaxin demonstrated a statistically significant survival advantage relative to existing animal-derived surfactants, Survanta(r) and Curosurf(r). Surfaxin is pending approval and has received an Approvable Letter from the United States Food and Drug Administration (FDA) for the prevention of RDS in premature infants.

The article published in Pediatrics is entitled: One-Year Follow-up of Very Preterm Infants Who Received Lucinactant for Prevention of Respiratory Distress Syndrome: Results from 2 Multicenter Randomized, Controlled Trials (Moya et al.) Pediatrics Vol. 119 No. 6 June 2007.

Fernando Moya, M.D., Chair of the SELECT study Steering Committee and Director of Neonatology at the Coastal Area Health Education Center, North Carolina, commented, "The long-term outcomes from the pooled analysis are particularly important because they suggest that a next-generation surfactant therapy, such as Surfaxin, may save more babies' lives while improving their chances for a healthy future. The prospective assessment of long-term outcomes from the SELECT and STAR trials is unique given direct comparisons between surfactant products. The data set from this recently published analysis sets a new bar for this category."

Key Data Highlights:

* Treatment with Surfaxin significantly improved survival (p=0.05) through one-year of life compared with animal-derived surfactants, Survanta and Curosurf.

* Surfaxin significantly improved survival (p=0.04) through one-year of life when directly compared with Curosurf, the current market lead
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric Academic Societies Annual Meeting
2. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
3. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
4. Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up
5. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
6. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
7. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
8. UCB Presents Long-Term CImzia Data in Crohns Disease
9. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
10. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
11. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
Post Your Comments:
(Date:5/1/2015)... May 1, 2015 Braeburn Pharmaceuticals ... current therapeutic focus beyond addiction and pain ... disorders. Braeburn has acquired an implantable, six-month ... risperidone for treatment of schizophrenia from Endo ... global rights to other potential applications of ...
(Date:5/1/2015)... May 1, 2015  Boston Scientific Corporation (NYSE: ... business momentum and long-term growth strategies at a meeting ... York City . President and Chief Executive Officer ... the company has to bring forward meaningful innovation to ... and deliver shareholder value. "We are ...
(Date:5/1/2015)... Cambrex Corporation (NYSE: CBM ) reports results for the ... , Sales increased 18% compared to the first ... driven by Innovator products and Controlled Substances. , EBITDA ... quarter of 2014. , GAAP Diluted EPS from continuing ... year and Adjusted Diluted EPS was $0.29 compared to $0.07 ...
Breaking Medicine Technology:Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 2Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 4Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 2Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 3Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 4Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 5Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 6Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 7Cambrex Reports First Quarter 2015 Financial Results 2Cambrex Reports First Quarter 2015 Financial Results 3Cambrex Reports First Quarter 2015 Financial Results 4Cambrex Reports First Quarter 2015 Financial Results 5Cambrex Reports First Quarter 2015 Financial Results 6Cambrex Reports First Quarter 2015 Financial Results 7Cambrex Reports First Quarter 2015 Financial Results 8Cambrex Reports First Quarter 2015 Financial Results 9Cambrex Reports First Quarter 2015 Financial Results 10Cambrex Reports First Quarter 2015 Financial Results 11
... drug used to treat erectile dysfunction and pulmonary ... and young adults with congenital heart disease to ... exercise performance during stress testing in patients with ... Children,s Hospital of Philadelphia. This study ...
... American Medical Systems® (AMS) (Nasdaq: AMMD ), ... male and female pelvic health, today announced the results ... Anterior and Apical Prolapse Repair System. The pelvic organ ... stage pelvic support, was implemented in the study and ...
Cached Medicine Technology:Exercise Performance in Children and Young Adults with Single Ventricle Heart Disease Improves with Use of Drug for Erectile Dysfunction 2Exercise Performance in Children and Young Adults with Single Ventricle Heart Disease Improves with Use of Drug for Erectile Dysfunction 3Six-Month Prospective Multi-Center Study Reports Efficacy Rates for AMS' Elevate Anterior and Apical Prolapse Repair System 2
(Date:5/3/2015)... 03, 2015 “ BolehVPN ” was featured ... features the latest and coolest technology products available to consumers. ... conducted the review and shared with viewers how to protect ... these days is on computers and even more so online. ... meet people all over the world. In terms of work, ...
(Date:5/3/2015)... is not too late to register to take part in the ... Been in Arnold, Missouri on May 9, 2015. Family and ... loving memory. It has benefited the renowned Brain Aneurysm Foundation each ... suffered a brain aneurysm . After two operations and five ... designed to serve as a remembrance of her and to help ...
(Date:5/2/2015)... 02, 2015 Vancouver fencing company, QS Fencing, ... valuable advice to prospective clients related to their questions on ... install railings around their decks and patios. While that seems ... pop up once the person rolls up their sleeve to ... a railing in finding a gate that matches it. , ...
(Date:5/2/2015)... 2015 We are pleased to announce ... Center as one of the Top Workplaces of 2015. ... addiction treatment field for their ethics and standards of ... to continue their educational efforts. The Delray Recovery Center ... forgetting their purpose – to help individuals heal from ...
(Date:5/2/2015)... As a nonsurgical staple in the ... neck and décolleté, radiofrequency energy is proving to ... the success of vulvovaginal rejuvenation. In a pilot ... ThermiGyn’s Women’s Health Clinical Advisory Board Chairman Red ... temperature controlled radio frequency, specifically that of ThermiVa, ...
Breaking Medicine News(10 mins):Health News:A Method to Keep Private Information Secure was Featured on NewsWatch Television 2Health News:Renowned Brain Aneurysm Foundation to Benefit from Arnold, Missouri’s 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been 2Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:The Delray Recovery Center Named 2015 Top Workplace 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3
... Americans United for Life,(AUL) today filed an amicus ... and should be upheld., AUL Staff Counsel Mailee ... has affirmed that states have a significant interest in,protecting ... That is,precisely what the Act does.", AUL Vice ...
... Two new guides to,help consumers and clinicians prevent and ... Department of Health and Human Services, Agency,for Healthcare Research ... but deep vein thrombosis, a blood clot,that forms in ... the lower leg or,thigh, is a potentially deadly medical ...
... for Global Health (HIGH) has been selected to receive ... from the National Institutes of Health,s Fogarty International Center., ... additional $300,000 grant from the University and support HIGH,s ... The grant will fund the Fostering Opportunities for Nutrition ...
... atypical antipsychotic medications were no more effective than an ... and may lead to more metabolic side effects, according ... of Health,s National Institute of Mental Health (NIMH). The ... 2008, in the American Journal of Psychiatry . ...
... in affected areas, WASHINGTON, Sept. 14 One ... a Category 2 hurricane, the American,Red Cross is providing ... of residents affected by the powerful storm. Although it ... storm rain and,high winds throughout Arkansas as it heads ...
... Concussion most common danger, expert says, so head, face ... News) -- Children who play school sports need to ... injuries, emphasizes the director of sports medicine at Cincinnati ... recommends the following equipment for young athletes: , ...
Cached Medicine News:Health News:VA Partial Birth Abortion Infanticide Act Constitutional, Should Be Upheld, Argues Americans United for Life Brief 2Health News:AHRQ Releases Two New Resources to Help Consumers and Clinicians Prevent Dangerous Blood Clots 2Health News:AHRQ Releases Two New Resources to Help Consumers and Clinicians Prevent Dangerous Blood Clots 3Health News:Harvard University recipient of Global Health Nutrition grant 2Health News:Newer antipsychotics no better than older drug in treating child and adolescent schizophrenia 2Health News:Red Cross Urges Safety in Wake of Hurricane Ike 2Health News:Red Cross Urges Safety in Wake of Hurricane Ike 3Health News:Safety Gear a Must to Prevent Kids' Sports Injuries 2
... well as humidification, try Flo-Mist™., ,Flo-Mist™, ... continuous medication nebulizer (CMN), engineered to deliver ... ml reservoir and jet flow design allow ... medication delivery at 25 ml/hr. Particles are ...
... Innovators in Anesthesia and Respiratory Products, ... medical devices for Anesthesia and Respiratory professionals. ... products that enhance the clinician's ability to ... attention to the bottom line. , ...
... Why design a nebulizer for this age ... coordinating inspiratory effort with actuation of an MDI. ... minimum inspiratory flow rate to achieve efficiency. , ... efficiency. , ,Blowby techniques often used for ...
... The new PARI TREK™ Compact Compressor ... take their aerosol treatments anywhere and everywhere. ... powerful. Three versatile power source optionsworldwide AC ... and rechargeable battery, permit patients the freedom ...
Medicine Products: